Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis

Journal of the National Medical Association

Volumn 98, Issue 10, 2006, Pages 1697-1699

  Seeyave, Desiree ^a,b   Desai, Ninad ^a,b   Miller, Scott ^a,b   Rao, Sreedhar P ^a,b   Piecuch, Steve ^a,b,c  

^a Downstate Medical Center ^*

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Blood transfusion; Infection; Serratia marcescens; Sickle cell anemia

Indexed keywords

CEFTRIAXONE; CLARITHROMYCIN; FOSPHENYTOIN SODIUM; LORAZEPAM; PARACETAMOL; SULTAMICILLIN;

ADOLESCENT; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DELAYED HYPERSENSITIVITY; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; PRIORITY JOURNAL; SEPSIS; SERRATIA MARCESCENS; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, HEMOLYTIC; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; FATAL OUTCOME; FEMALE; HUMANS; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

EID: 33750603930     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Talano JA, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111:e661-e665.
2. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:382-392.
3. Roose WF, Narla M, Petz LD, et al. New views of sickle cell disease pathophysiology and treatment. Hematology (Am Soc Hematol Educ Program). 2000;2-17.
4. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41:323-328.
5. Pineda AA, Taswell HF, Brzica SM Jr. Transfusion reaction. An immunologic hazard of blood transfusion. Transfusion. 1978;18:1-7.
6. Garratty G, Telen MJ, Petz LD. Red cell antigens as functional molecules and obstacles to transfusion. Hematology (Am Soc Hematol Educ Program). 2002;445-462.
7. Aken'ova YA, Bakare RA, Okunade MA. Septicaemia in sickle cell anaemia patients: the Ibadan experience. Cent Afr J Med. 1998;44:102-104.
8. Wierenga KJ, Hambleton IR, Wilson RM, et al. Significance of fever in Jamaican patients with homozygous sickle cell disease. Arch Dis Child. 2001;84:156-159.
9. Bernini JC, Mustafa MM, Sutor LJ, et al. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia. J Pediatr. 1995;126:813-815.
10. Bochud P-Y, Bonten M, Marchetti O, et al. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(11 suppl):S495-S512.